Abstract: An optical setup, comprising one or more platforms having a plurality of fixation locations repeatedly arranged, and defining a discrete position coordinate system; and a plurality of modular optical units, each comprising an optical portion defining an optical axis fixedly attached to at least one mounting surface comprising complementary geometry to the fixation locations; wherein a releasable attachment of the plurality of modular optical units at the fixation locations defines a plurality of optical axes at least a portion of the optical axes overlapping across the discrete position coordinate system In some embodiments, the modular optical units include standard optical elements In some embodiments, the platform includes an attachment interface to an optical table and/or another platform In some embodiments, laser pulses are synchronized by fixing a discrete path length over the fixation locations In some embodiments the fixation locations are located on multiple planes in 3D space.

Abstract: A method of performing Principal Component Analysis is provided. The method includes receiving, by a computing device, evolving data for processing/visualization. The method further includes, by the computing device, a dimensionality for reducing of the evolving data using the PCA, wherein the PCA is performed on analog crossbar hardware. The method also includes using, by the computing device, the evolving data for visualization having the dimensionality thereof reduced by the principal component analysis for a further application.

Abstract: The technology disclosed in this patent document can be used to implement an optical device for generating broadband optical pulses, including an optical waveguide having different waveguide structures at different locations along the optical waveguide and with varying dimensions or pressure gradient that change adiabatically along the different locations to enable non-linear four wave mixing over a broad spectral range.

Abstract: The present invention relates to a unique oncolytic virus, Epizootic Hemorrhagic Disease virus-Tel Aviv University (EHDV-TAU), and to methods and pharmaceutical compositions comprising thereof for preventing or treating cancer exhibiting an alteration in interferon signaling and/or the innate immune antiviral response.

Abstract: A method for Peak to Average Power Ratio (PAPR) reduction at an input of analog to digital converter (ADC) of the receiver, the method includes mapping, by a mapper, an input symbol to an output symbol that maintains a peak power constraint at the input of the ADC; wherein the mapping is responsive to (a) previously transmitted symbols and (b) a state of the channel following a transmission of the current output symbol; transmitting the output symbol by the transmitter; receiving, by the receiver, a received symbol that represents the output symbol; and de-mapping the received symbol, by a de-mapper of the receiver, to a de-mapped symbol that represents the input symbol.

Abstract: A neural network system for detecting at least one object in at least one image, the system includes a plurality of object detectors. Each object detector receives respective image information thereto. Each object detector includes a respective neural network. Each the neural network including a plurality of layers. Layers in different object detectors are common layers when the layers receive the same input thereto and produce the same output therefrom. Common layers are computed only once during object detection for all the different object detectors.

Abstract: A method of treating Alzheimer's Disease (AD) is disclosed. The method comprises administering to the subject a therapeutically effective amount of an agent which prevents the binding of amyloid precursor protein (APP) to Tau protein.

Abstract: A new family of mononuclear organometallic complexes of a divalent metal bound to sequential tetradentate monoanionic {ONNN}-type ligands, and polymerization of cyclic esters such as lactides utilizing same are provided. Novel tetradentate monoanionic {ONNN}-type ligands usable for forming these complexes are also provided.

Abstract: A human antibody comprising an antigen binding domain which binds PstS1 of Mycobacterium tuberculosis (TB) for use in preventing or treating TB infection in a subject in need thereof is provided. Also provided are vaccine compositions and conjugates of such antibodies.

Abstract: Methods and kits for detecting the presence of at least one target DNA sequence with or without a modification in a DNA molecule are provided.

Abstract: Novel compounds usable in modulating an activity or function of a voltage-dependent potassium channel and/or of TRPV1 are provided. The compounds are represented by Formula I as described and defined in the specification.

Abstract: The present invention provides cell-free systems comprising: (i) a transcription compartment; (ii) a barrier; and (iii) a translation compartment, methods for producing proteins and performing post-translational modifications thereon using such systems, and kits comprising such systems.

Abstract: A signature verification system, which comprises a plurality of worn devices of signing users, each provided with one or more motion sensors, and a processor for receiving motion signals from the sensors, the processor is adapted to define a set of features that describe a signature and distinguish one signature from another; perform a training phase by obtaining motion signals from one or more motion sensors of the worn devices; training a machine learning classifier using the instances and labels; obtain motion signals from motion sensors of the a worn device, the motion being of an allegedly genuine signature of one of the users; scale and domain transform the allegedly genuine signature; calculate values of the features describing the allegedly genuine signature with respect to scaled and transformed reference signatures of the one of the users; and apply the trained classifier on the feature values, thereby classifying the allegedly genuine signature as genuine or forged.

Abstract: Antibodies comprising an antigen recognition region which binds a semaphorin 3A (Sema3A) are disclosed. Uses thereof are also disclosed.

Abstract: Compositions and methods of using same for tissue regeneration are provided. Accordingly, there is provided a composition comprising a hyaluronic acid, a laminin polypeptide, an antioxidant and Copolymer 1 at a concentration range of 10-150 microgram/ml. Also provided is a composition comprising a hyaluronic acid, a laminin polypeptide and vitamin E at a concentration range of 0.3-30 mM. Also provided are matrices and hydrogels of the compositions and methods of using same.

Abstract: Method for mapping the transverse relaxation times (T2) in a magnetic resonance imaging (MRI) scan defined over a plurality of pixels, where each pixel is associated with a multicomponent T2 (mcT2) signal, comprises: accessing a computer readable medium storing an mcT2 dictionary having a set of synthetic mcT2 signals, and selecting a subset of synthetic mcT2 signals for which correlations between the synthetic mcT2 signals and pixels in the MRI scan are highest among the set. For each of at least a portion of the pixels, a respective mcT2 scan signal is fitted to the subset to provide, a plurality of T2 values for the pixel. A T2 map of the MRI scan is generated based on the T2 values.

Abstract: Deferred treatment of nerve injuries is provided. Accordingly, there is provided a method of deferred treatment of a nerve injury in a subject in need thereof, the method comprising implanting at least 1 week following onset or diagnosis of the nerve injury in the subject a composition comprising a hyaluronic acid, a laminin polypeptide and an antioxidant at or near the nerve injury of the subject.

Abstract: A method of detecting a presence, amount and/or type of a pathogenic organism in a substrate is provided. The method is effected by contacting a sample suspected as containing the pathogenic organism or a portion thereof with an electrode, thereafter contacting the electrode with an aptamer that selectively binds to said pathogenic organism; thereafter contacting the electrode with an agent that participates in an electrochemically detectable reaction and thereafter perform the electrochemical reaction while using the electrode. The electric signal produced by the reaction is indicative of a presence and/or amount of the pathogenic organism. Also provided are a sensing system and kits usable for practicing the method, and use of the method for determining a suitable agent for reducing a load of a pathogenic organism in a substrate.

Abstract: Structures for response shaping in frequency and time domain, include an optical response shaper and/or a modulator device with multiple injection. The device comprises a resonator having an enclosed geometric structure, for example a ring or racetrack structure, at least two injecting optical waveguides approaching the resonator to define at least two coupling regions between the resonator and the injecting waveguides, and may define at least two Free Spectral Range states. One or both of the coupling regions has a coupling coefficient selected for a predetermined frequency or time response, and the coupling coefficient or other device parameters may be variable, in some case in real time to render the response programmably variable. In addition, the injection power at one of the optical waveguides serves to modify the response.

Abstract: Disclosed herein is a neural network based pre-decoder comprising a permutation embedding engine, a permutation classifier each comprising one or more trained neural networks and a selection unit. The permutation embedding engine is trained to compute a plurality of permutation embedding vectors each for a respective one of a plurality of permutations of a received codeword encoded using an error correction code and transmitted over a transmission channel subject to interference. The permutation classifier is trained to compute a decode score for each of the plurality of permutations expressing its probability to be successfully decoded based on classification of the plurality of permutation embedding vectors coupled with the plurality of permutations. The selection unit is configured to output one or more selected permutations having a highest decode score. One or more decoders may be then applied to recover the encoded codeword by decoding the one or more selected permutations.